Remco G A Erkens

6PUBLICATIONS
26CO-AUTHORS
Medical mycologyAutoimmunityInnate immunityGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 21, 2026
Treatment approaches to macrophage activation syndrome in real life and priorities for future research: results from the international METAPHOR project.

|Sep 01, 2026
Persistent Interleukin-18 Fuels Expansion of CD38+HLA-DR+CD8+ T Cells in Still Disease and Macrophage Activation Syndrome.

|Aug 25, 2026
Complement Activation Linked to Type II Interferon Signaling in Still Disease.

|May 29, 2026
Native long-read RNA sequencing of human monocytes reveals activation-induced alternative splicing toward functional isoforms.

|May 27, 2025
Impact of Interleukin-1 Blockade on the Development of Macrophage Activation Syndrome in Still Disease: Incidence and Diagnostic Validity of the EULAR/ACR/PRINTO 2016 MAS Classification Criteria.

Remco G A Erkens, Greta Rogani, Laura Huber

|Jul 20, 2023
Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN Variants.

Remco G A Erkens, Jorg J A Calis, Anouk Verwoerd

Pageof 1

Frequent Collaborators

3 joint publications

Alejandra Bodelón

3 joint publications

Greta Rogani

2 joint publications

Grant Schulert

2 joint publications

Freya M C H Huijsmans